| 000 | 01581 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514191058.0 | ||
| 264 | 0 | _c20050128 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1099-498X | ||
| 024 | 7 |
_a10.1002/jgm.567 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWorthington, Jenny | |
| 245 | 0 | 0 |
_aUse of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. _h[electronic resource] |
| 260 |
_bThe journal of gene medicine _cJun 2004 |
||
| 300 |
_a673-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGenetic Vectors _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xradiation effects |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 | _aX-Rays |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aMcCarthy, Helen O | |
| 700 | 1 | _aBarrett, Eimear | |
| 700 | 1 | _aAdams, Catherine | |
| 700 | 1 | _aRobson, Tracy | |
| 700 | 1 | _aHirst, David G | |
| 773 | 0 |
_tThe journal of gene medicine _gvol. 6 _gno. 6 _gp. 673-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jgm.567 _zAvailable from publisher's website |
| 999 |
_c14878579 _d14878579 |
||